SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date or Report (Date of earliest event reported): April 17, 1997
BIOTECHNICA INTERNATIONAL, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-11854 22-2344703
(State or other jurisdiction of (Commission File (I.R.S. Employer
incorporation or organization) Number) Identification No.)
4001 North War Memorial Drive, Peoria, IL 61614
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: 309/681-0300
_____________________________________________________________
(Former name or former address, if changed since last report)
ITEM 5. OTHER EVENTS
FOR IMMEDIATE RELEASE: April 17, 1997
CONTACT: Bruno Carette, President and Chief Operating Officer
Edward M. Germain, Chief Financial Officer
BioTechnica International, Inc.
4001 N. War Memorial Drive - Suite 200
Peoria, IL 61614
(309) 681-0300
BIOTECHNICA INTERNATIONAL, INC. ANNOUNCES THAT THE
NASDAQ-NMS HAS DELISTED THE COMPANY'S COMMON STOCK
BioTechnica International, Inc. (NASDAQ: BIOT) (the "Company") has been
informed by The NASDAQ Stock Market, Inc. that the Common Stock of the
Company has been de-listed by the NASDAQ National Market System effective
April 17, 1997. This action of the NASDAQ Stock Market, Inc. was taken
subsequent to the filing of an appeal by the Company to remain on the
National Market System dated March 31, 1997. The NASDAQ Stock Market, Inc.
has informed the Company that it may be eligible to trade on the OTC
Bulletin Board.
BioTechnica International, Inc. is an agricultural products company
dedicated principally to the production and marketing of proprietary
hybrid corn, soybean, alfalfa, and other field seed products throughout
the Midwest Corn Belt region of the United States.
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
BioTechnica International Inc.
By: /s/ Edward M Germain
Date: April 17, 1997 Edward M Germain
Chief Financial Officer
